114 Western Avenue
About Shepherd Therapeutics
The mission of Shepherd is to cure rare cancers. Founded by a rare cancer patient, Shepherd is a biotechnology company relentlessly focused on using deep disease understanding, development expertise, and an unwavering commitment to save people dying of neglected rare cancers. Shepherd is changing the traditional economics and timeline of drug development, delivering better treatments faster for patients who previously had none. To join the mission or learn more, visit shepherd.bio.
Founders: Eugene Williams and David Hysong
Founder and CEO: David Hysong
CSO: Johanne Kaplan
CMO and CBO: Abby V. Reiner
COO: Elizabeth Hostetter
CRO: Jamie Dempsey Barber
CCO: Lacie Randall
CDO: William Siders
3 articles with Shepherd Therapeutics
5/1/2018Biopharmaceutical companies are focusing their drugs for smaller and smaller and more clearly delineated patient populations. No longer is a drug for lung cancer or even non-small cell lung cancer, but a much smaller segment.
There are many unusual things about Shepherd Therapeutics, but one of them is its origin.
BioSpace is proud to present its NextGen "Class of 2018," a list of 20 up-and-coming life science companies in North America that started up no earlier than 2015.